Michael Bengtson

738 total citations
16 papers, 494 citations indexed

About

Michael Bengtson is a scholar working on Psychiatry and Mental health, Clinical Psychology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Michael Bengtson has authored 16 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 5 papers in Clinical Psychology and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Michael Bengtson's work include Schizophrenia research and treatment (7 papers), Attention Deficit Hyperactivity Disorder (5 papers) and Obsessive-Compulsive Spectrum Disorders (3 papers). Michael Bengtson is often cited by papers focused on Schizophrenia research and treatment (7 papers), Attention Deficit Hyperactivity Disorder (5 papers) and Obsessive-Compulsive Spectrum Disorders (3 papers). Michael Bengtson collaborates with scholars based in United States, Qatar and Serbia. Michael Bengtson's co-authors include Tanya K. Murphy, Eric A. Storch, Wayne K. Goodman, Gary R. Geffken, Mark Yang, Jamie A. Micco, Aude Henin, Adam B. Lewin, Sabine Wilhelm and Daniel Geller and has published in prestigious journals such as Biological Psychiatry, The FASEB Journal and Psychiatric Services.

In The Last Decade

Michael Bengtson

16 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Bengtson United States 10 290 196 150 93 83 16 494
Elisa Lorch United States 6 237 0.8× 234 1.2× 105 0.7× 92 1.0× 102 1.2× 8 460
Aisling O’Neill United Kingdom 13 184 0.6× 197 1.0× 221 1.5× 101 1.1× 110 1.3× 28 602
Evelyn Kiive Estonia 16 236 0.8× 157 0.8× 148 1.0× 74 0.8× 201 2.4× 42 686
B. Jabs Germany 15 136 0.5× 108 0.6× 204 1.4× 55 0.6× 95 1.1× 35 568
Sandra Villafuerte United States 15 169 0.6× 108 0.6× 78 0.5× 88 0.9× 179 2.2× 21 583
G. Camuri Italy 14 196 0.7× 139 0.7× 374 2.5× 96 1.0× 81 1.0× 28 743
Vadim D. Khait United States 7 149 0.5× 143 0.7× 149 1.0× 36 0.4× 139 1.7× 8 485
Paul Soloff United States 6 245 0.8× 170 0.9× 182 1.2× 59 0.6× 138 1.7× 10 626
Monica Bosi Italy 10 214 0.7× 111 0.6× 232 1.5× 144 1.5× 234 2.8× 22 735
Pavel Golubchik Israel 15 201 0.7× 264 1.3× 294 2.0× 54 0.6× 48 0.6× 41 608

Countries citing papers authored by Michael Bengtson

Since Specialization
Citations

This map shows the geographic impact of Michael Bengtson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Bengtson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Bengtson more than expected).

Fields of papers citing papers by Michael Bengtson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Bengtson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Bengtson. The network helps show where Michael Bengtson may publish in the future.

Co-authorship network of co-authors of Michael Bengtson

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Bengtson. A scholar is included among the top collaborators of Michael Bengtson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Bengtson. Michael Bengtson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Nadai, Alessandro S. De, Marc S. Karver, Tanya K. Murphy, et al.. (2016). Common Factors in Pediatric Psychiatry: A Review of Essential and Adjunctive Mechanisms of Treatment Outcome. Journal of Child and Adolescent Psychopharmacology. 27(1). 10–18. 6 indexed citations
2.
Obregon, Demian, Yuyan Zhu, Huayan Hou, et al.. (2014). Potential Autoepitope within the Extracellular Region of Contactin-Associated Protein-like 2 in Mice. British Journal of Medicine and Medical Research. 4(1). 416–432. 1 indexed citations
3.
Constantine, Robert, et al.. (2012). Impact of the Florida Medicaid Prior-Authorization Program on Use of Antipsychotics by Children Under Age Six. Psychiatric Services. 63(12). 1257–1260. 8 indexed citations
4.
Constantine, Robert, et al.. (2011). Exposure to antipsychotic medications over a 4‐year period among children who initiated antipsychotic treatment before their sixth birthday. Pharmacoepidemiology and Drug Safety. 21(2). 152–160. 16 indexed citations
5.
Hou, Huayan, Demian Obregon, Jun Tian, et al.. (2011). Aberrant T‐lymphocyte development and function in mice overexpressing human soluble amyloid precursor protein‐α: implications for autism. The FASEB Journal. 26(3). 1040–1051. 15 indexed citations
6.
Storch, Eric A., Tanya K. Murphy, Wayne K. Goodman, et al.. (2010). A Preliminary Study of D-Cycloserine Augmentation of Cognitive-Behavioral Therapy in Pediatric Obsessive-Compulsive Disorder. Biological Psychiatry. 68(11). 1073–1076. 139 indexed citations
7.
Murphy, Tanya K., P. Jane Mutch, Jeannette M. Reid, et al.. (2009). Open Label Aripiprazole in the Treatment of Youth with Tic Disorders. Journal of Child and Adolescent Psychopharmacology. 19(4). 441–447. 47 indexed citations
8.
Ried, L. Douglas, et al.. (2009). Glucose dysregulation among veterans living with schizophrenia-related disorders after switching second-generation antipsychotics. Journal of the American Pharmacists Association. 49(2). 223–231. 2 indexed citations
9.
Leonard, Christiana M., et al.. (2008). Identical neural risk factors predict cognitive deficit in dyslexia and schizophrenia.. Neuropsychology. 22(2). 147–158. 25 indexed citations
10.
Ried, L. Douglas, et al.. (2008). Metabolic monitoring in veterans with schizophrenia-related disorders and treated with second-generation antipsychotics: Findings from a Veterans Affairs–based population. Journal of the American Pharmacists Association. 48(3). 393–400. 18 indexed citations
11.
Ried, L. Douglas, et al.. (2007). Effect on lipid profiles of switching from olanzapine to another secondgeneration antipsychotic agent in veterans with schizophrenia. Journal of the American Pharmacists Association. 47(3). 373–378. 16 indexed citations
12.
Storch, Eric A., Lisa J. Merlo, Michael Bengtson, et al.. (2007). D-cycloserine does not enhance exposure–response prevention therapy in obsessive–compulsive disorder. International Clinical Psychopharmacology. 22(4). 230–237. 146 indexed citations
13.
Ried, L. Douglas, et al.. (2007). Weight and blood pressure changes after switching second-generation antipsychotics in a population of veterans with schizophrenia-related disorders. Journal of the American Pharmacists Association. 47(2). 156–164. 4 indexed citations
14.
Ried, L. Douglas, et al.. (2006). Increased Cardiovascular Risk with Second-Generation Antipsychotic Agent Switches. Journal of the American Pharmacists Association. 46(4). 491–501. 5 indexed citations
15.
Ried, L. Douglas, et al.. (2003). Weight Change after an Atypical Antipsychotic Switch. Annals of Pharmacotherapy. 37(10). 1381–1386. 18 indexed citations
16.
Murphy, Tanya K., et al.. (2000). Selective serotonin reuptake inhibitors in the treatment of paediatric anxiety disorders: a review. International Clinical Psychopharmacology. 15. S47–S63. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elisa Lorch Breakdown of academic impact, for papers by Aisling O’Neill Breakdown of academic impact, for papers by Evelyn Kiive Breakdown of academic impact, for papers by B. Jabs Breakdown of academic impact, for papers by Sandra Villafuerte Breakdown of academic impact, for papers by G. Camuri Breakdown of academic impact, for papers by Vadim D. Khait Breakdown of academic impact, for papers by Paul Soloff Breakdown of academic impact, for papers by Monica Bosi Breakdown of academic impact, for papers by Pavel Golubchik
Rankless by CCL
2026